175 related articles for article (PubMed ID: 28628428)
21. Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women.
Pinkerton JV; Stovall DW
Expert Opin Investig Drugs; 2010 Dec; 19(12):1613-21. PubMed ID: 21073353
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
Mortimer JE
Geriatrics; 2002 Sep; 57(9):25-31. PubMed ID: 12271826
[TBL] [Abstract][Full Text] [Related]
23. Treatment of menopausal vasomotor symptoms.
Med Lett Drugs Ther; 2004 Dec 6-20; 47(1197-1198):98-9. PubMed ID: 15583526
[TBL] [Abstract][Full Text] [Related]
24. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
Komm BS; Mirkin S; Jenkins SN
Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
[TBL] [Abstract][Full Text] [Related]
25. Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials.
Archer DF; Freeman EW; Komm BS; Ryan KA; Yu CR; Mirkin S; Pinkerton JV
J Womens Health (Larchmt); 2016 Nov; 25(11):1102-1111. PubMed ID: 27676118
[TBL] [Abstract][Full Text] [Related]
26. Approach to the patient with menopausal symptoms.
Martin KA; Manson JE
J Clin Endocrinol Metab; 2008 Dec; 93(12):4567-75. PubMed ID: 19056840
[TBL] [Abstract][Full Text] [Related]
27. [Hormone replacement therapy].
Nozaki M
Nihon Rinsho; 2006 Apr; 64 Suppl 4():406-10. PubMed ID: 16689342
[No Abstract] [Full Text] [Related]
28. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
[TBL] [Abstract][Full Text] [Related]
29. Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms.
Mirkin S; Ryan KA; Chandran AB; Komm BS
Maturitas; 2014 Jan; 77(1):24-31. PubMed ID: 24246155
[TBL] [Abstract][Full Text] [Related]
30. The evolving role of specific estrogen receptor modulators (SERMs).
Ibrahim NK; Hortobagyi GN
Surg Oncol; 1999 Aug; 8(2):103-23. PubMed ID: 10732962
[TBL] [Abstract][Full Text] [Related]
31. Isoflavones and women's health.
Powles T
Breast Cancer Res; 2004; 6(3):140-2. PubMed ID: 15084236
[TBL] [Abstract][Full Text] [Related]
32. Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.
Mirkin S; Komm B; Pickar JH
Womens Health (Lond); 2014 Mar; 10(2):135-46. PubMed ID: 24601804
[TBL] [Abstract][Full Text] [Related]
33. [Menopause and hormone replacement therapy].
Tóth KS
Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
[TBL] [Abstract][Full Text] [Related]
34. Menopausal hot flushes and night sweats: where are we now?
Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
[TBL] [Abstract][Full Text] [Related]
35. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.
Crandall C
J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124
[TBL] [Abstract][Full Text] [Related]
36. What happened to WHI: menopausal hormonal therapy in 2012.
Hansen KA; Eyster KM
Clin Obstet Gynecol; 2012 Sep; 55(3):706-12. PubMed ID: 22828102
[TBL] [Abstract][Full Text] [Related]
37. Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.
Pinkerton JV; Utian WH; Constantine GD; Olivier S; Pickar JH
Menopause; 2009; 16(6):1116-24. PubMed ID: 19546826
[TBL] [Abstract][Full Text] [Related]
38. Hormone therapy for the management of menopause symptoms.
Collins Fantasia H; Sutherland MA
J Obstet Gynecol Neonatal Nurs; 2014; 43(2):226-35; quiz E18-9. PubMed ID: 24502325
[TBL] [Abstract][Full Text] [Related]
39. Management of menopause in women with breast cancer.
Vincent AJ
Climacteric; 2015 Oct; 18(5):690-701. PubMed ID: 25536007
[TBL] [Abstract][Full Text] [Related]
40. Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.
Tane K; Egawa C; Takao S; Yamagami K; Miyashita M; Baba M; Ichii S; Konishi M; Kikawa Y; Minohata J; Okuno T; Miyauchi K; Wakita K; Suwa H; Hashimoto T; Nishino M; Matsumoto T; Hidaka T; Konishi Y; Sakoda Y; Miya A; Kishimoto M; Nishikawa H; Kono S; Kokufu I; Sakita I; Kitatsuji K; Oh K; Akazawa K; Miyoshi Y
Breast Cancer; 2017 Jul; 24(4):528-534. PubMed ID: 27730528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]